Pore-forming bacterial toxins and antimicrobial peptides as modulators of ADAM function

Reiss, Karina; Bhakdi, Sucharit
November 2012
Medical Microbiology & Immunology;Nov2012, Vol. 201 Issue 4, p419
Academic Journal
Membrane-perturbating proteins and peptides are widespread agents in biology. Pore-forming bacterial toxins represent major virulence factors of pathogenic microorganisms. Membrane-damaging peptides constitute important antimicrobial effectors of innate immunity. Membrane perturbation can incur multiple responses in mammalian cells. The present discussion will focus on the interplay between membrane-damaging agents and the function of cell-bound metalloproteinases of the ADAM family. These transmembrane enzymes have emerged as the major proteinase family that mediate the proteolytic release of membrane-associated proteins, a process designated as 'shedding'. They liberate a large spectrum of functionally active molecules including inflammatory cytokines, growth factor receptors and cell adhesion molecules, thereby regulating such vital cellular functions as cell-cell adhesion, cell proliferation and cell migration. ADAM activation may constitute part of the cellular recovery machinery on the one hand, but likely also promotes inflammatory processes on the other. The mechanisms underlying ADAM activation and the functional consequences thereof are currently the subject of intensive research. Attention here is drawn to the possible involvement of purinergic receptors and ceramide generation in the context of ADAM activation following membrane perturbation by membrane-active agents.


Related Articles

  • The role of the inflammasome in cellular responses to toxins and bacterial effectors. Freche, Barbara; Reig, Núria; Goot, F. // Seminars in Immunopathology;Sep2007, Vol. 29 Issue 3, p249 

    Invading pathogens are recognized by mammalian cells through dedicated receptors found either at the cell surface or in the cytoplasm. These receptors, like the trans-membrane Toll-like Receptors (TLR) or the cytosolic Nod-like Receptors (NLR), initiate innate immunity after recognition of...

  • Microbial Symbiosis with the Innate Immune Defense System of the Skin. Gallo, Richard L; Nakatsuji, Teruaki // Journal of Investigative Dermatology;Oct2011, Vol. 131 Issue 10, p1974 

    Skin protects itself against infection through a variety of mechanisms. Antimicrobial peptides (AMPs) are major contributors to cutaneous innate immunity, and this system, combined with the unique ionic, lipid, and physical barrier of the epidermis, is the first-line defense against invading...

  • Short antimicrobial peptides as cosmetic ingredients to deter dermatological pathogens. Rahnamaeian, Mohammad; Vilcinskas, Andreas // Applied Microbiology & Biotechnology;Nov2015, Vol. 99 Issue 21, p8847 

    Antimicrobial peptides (AMPs) are components of the innate immune system in many species of animals. Their diverse spectrum of activity against microbial pathogens, both as innate defense molecules and immunomodulators, makes them attractive candidates for the development of a new generation of...

  • A hitchhiker's guide to the nervous system: the complex journey of viruses and toxins. Salinas, Sara; Schiavo, Giampietro; Kremer, Eric J. // Nature Reviews Microbiology;Sep2010, Vol. 8 Issue 9, p645 

    To reach the central nervous system (CNS), pathogens have to circumvent the wall of tightly sealed endothelial cells that compose the blood–brain barrier. Neuronal projections that connect to peripheral cells and organs are the Achilles heels in CNS isolation. Some viruses and bacterial...

  • Molecular Hazard Identification of Non-O157 Shiga Toxin-Producing Escherichia coli (STEC). Franz, Eelco; van Hoek, Angela H. A. M.; Wuite, Mark; van der Wal, Fimme J.; de Boer, Albert G.; Bouw, EI; Aarts, Henk J. M. // PLoS ONE;Mar2015, Vol. 10 Issue 3, p1 

    The complexity regarding Shiga toxin-producing Escherichia coli (STEC) in food safety enforcement as well as clinical care primarily relates to the current inability of an accurate risk assessment of individual strains due to the large variety in serotype and genetic content associated with...

  • Sensing by bacterial regulatory systems in host and non-host environments. Groisman, Eduardo A.; Mouslim, Chakib // Nature Reviews Microbiology;Sep2006, Vol. 4 Issue 9, p705 

    Free-living organisms have the ability to gauge their surroundings and modify their gene expression patterns in ways that help them cope with new environments. Here we discuss the physiological significance of recent reports describing the ability of the Salmonella typhimurium PhoP/PhoQ...

  • A Streptococcus pneumoniae infection model in larvae of the wax moth Galleria mellonella. Evans, B.; Rozen, D. // European Journal of Clinical Microbiology & Infectious Diseases;Oct2012, Vol. 31 Issue 10, p2653 

    The bacterium Streptococcus pneumoniae is a leading human opportunistic pathogen. The limitations of the current vaccine have led to increased recognition of the need to understand bacterial behaviour and competitive dynamics using in vivo models of infection. Here, we investigate the potential...

  • The Roles of Antimicrobial Peptides in Innate Host Defense. Diamond, Gill; Beckloff, Nicholas; Weinberg, Aaron; Kisich, Kevin O. // Current Pharmaceutical Design;7/21/2009, Vol. 15 Issue 21, p2377 

    Antimicrobial peptides (AMPs) are multi-functional peptides whose fundamental biological role in vivo has been proposed to be the elimination of pathogenic microorganisms, including Gram-positive and -negative bacteria, fungi, and viruses. Genes encoding these peptides are expressed in a variety...

  • Anti- Candida activity of 1-18 fragment of the frog skin peptide esculentin-1b: in vitro and in vivo studies in a Caenorhabditis elegans infection model. Luca, Vincenzo; Olivi, Massimiliano; Grazia, Antonio; Palleschi, Claudio; Uccelletti, Daniela; Mangoni, Maria // Cellular & Molecular Life Sciences;Jul2014, Vol. 71 Issue 13, p2535 

    Candida albicans represents one of the most prevalent species causing life-threatening fungal infections. Current treatments to defeat Candida albicans have become quite difficult, due to their toxic side effects and the emergence of resistant strains. Antimicrobial peptides (AMPs) are...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics